Role of corticosteroid therapy in IgA nephropathy; where do we stand?

Role of corticosteroid therapy in IgA nephropathy; where do we stand?

Background: Current KDIGO guidelines suggest corticosteroids (CS) administration in IgA nephropathy (IgAN) with persistent proteinuria >1 g/d despite 3-6 months of supportive care and estimated glomerular filtration rate (eGFR) >50 mL/min/1.73 m2 . The benefits of CS in patients with eGFR <...

Full description

Bibliographic Details
Main Authors: Shankar Prasad Nagaraju, Sindhura Lakshmi Koulmane Laxminarayana, Aswani Srinivas Mareddy, Srikanth Prasad, Sindhu Kaza, Srinivas Shenoy, Karan Saraf, Dharshan Rangaswamy, Ravindra Prabhu Attur, Rajeevalochana Parthasarathy, Uday Venkat Mateti, Vasudeva Guddattu, Mahesha Vankalakunti
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2017-10-01
Series:Journal of Nephropathology
Subjects:
iga nephropathy
egfr
corticosteroids
immunosuppression
proteinuria
Online Access:https://nephropathol.com/PDF/jnp-6-368.pdf

Internet

https://nephropathol.com/PDF/jnp-6-368.pdf

Similar Items